These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6504178)

  • 1. [Acetosal and the heart].
    Verheugt FW
    Ned Tijdschr Geneeskd; 1984 Oct; 128(41):1951-3. PubMed ID: 6504178
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aspirin in ischemic heart disease].
    Penkov N; Sirakova V
    Vutr Boles; 1990; 29(4):12-7. PubMed ID: 2281654
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental basis of platelet aggregation inhibition by acetylsalicylic acid.
    Born GV; Görög P; Begent NA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):719-24. PubMed ID: 6083947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of platelet inhibitor therapy in coronary artery disease.
    Harbold NB
    Coll Works Cardiopulm Dis; 1982 May; 23():1-3. PubMed ID: 7047065
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G
    Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incidence of thrombosis and the status of coagulation in ischaemic heart disease].
    Gormsen J; Andersen LA
    Ugeskr Laeger; 1974 Dec; 136(49):2727-35. PubMed ID: 4446097
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pro and con: Aggregation inhibitors in the prophylaxis of myocardial infarct. Arguments in favor of aggregation inhibitors].
    Walter E; Weber E
    Internist (Berl); 1980 Jul; 21(7):387-9. PubMed ID: 7007276
    [No Abstract]   [Full Text] [Related]  

  • 8. Effective platelet inhibition by aspirin and clopidogrel: where are we now?
    Tousoulis D; Briasoulis A; Dhamrait SS; Antoniades C; Stefanadis C
    Heart; 2009 May; 95(10):850-8. PubMed ID: 19401288
    [No Abstract]   [Full Text] [Related]  

  • 9. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aspirin as a platelet antiaggregant: indications and controversies].
    Stalder M; Bachmann F
    Ther Umsch; 1987 Aug; 44(8):584-90. PubMed ID: 3313789
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of prevention of second myocardial infarct with syncumar or aspirin].
    Kraska T; Malanowicz W; Skarzyńska M; Tymińska K
    Kardiol Pol; 1981; 24(9):593-7. PubMed ID: 7029110
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing death after myocardial infarction.
    Horwitz DL
    Compr Ther; 1980 Jun; 6(6):3-4. PubMed ID: 7379491
    [No Abstract]   [Full Text] [Related]  

  • 13. [The platelet inhibitor problem].
    Straub PW
    Schweiz Med Wochenschr; 1981 Apr; 111(14):478-82. PubMed ID: 7015489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pro and con: Anticoagulation or thrombocyte function inhibitors in the prophylaxis of myocardial infarct? Arguments in favor of thrombocyte function inhibitors].
    Breddin K
    Internist (Berl); 1980 Jul; 21(7):394-6. PubMed ID: 7007279
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet aggregation, coronary insufficiency and aspirin].
    Nicolau JC; Ramires JA
    Arq Bras Cardiol; 1990 Mar; 54(3):223-6. PubMed ID: 2288511
    [No Abstract]   [Full Text] [Related]  

  • 16. Can aspirin prevent myocardial infarction?
    Med Lett Drugs Ther; 1975 Mar; 17(6):25-6. PubMed ID: 1092992
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of aspirin in ischemic heart disease].
    Frishman W; Horwitz S
    Arch Inst Cardiol Mex; 1977; 47(2):129-31. PubMed ID: 901049
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of aspirin in ischemic heart disease.
    Willard JE; Lange RA; Hillis LD
    N Engl J Med; 1992 Jul; 327(3):175-81. PubMed ID: 1285747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Summary: Secondary prophylaxis following myocardial re-infarct. Anticoagulants or thrombocyte function inhibitors?].
    Breddin K; Loeliger EA
    Internist (Berl); 1980 Jul; 21(7):399. PubMed ID: 7007281
    [No Abstract]   [Full Text] [Related]  

  • 20. [Secondary prevention of myocardial infarct. Drug therapy].
    Widimský J
    Vnitr Lek; 1982 Mar; 28(3):248-56. PubMed ID: 6126041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.